{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:22:19Z","timestamp":1790709739714,"version":"4.1.0"},"reference-count":36,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2001,2,1]],"date-time":"2001-02-01T00:00:00Z","timestamp":980985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2001,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Dendritic cells are potent antigen-presenting cells that also produce interleukin-12 (IL-12) during innate and adaptive cellular immune responses and that thereby promote the differentiation of gamma interferon (IFN-\u03b3)-producing Th1-type CD4<jats:sup>+<\/jats:sup>T lymphocytes. We hypothesized that expanded dendritic-cell populations in mice pretreated with the hematopoietic cytokine Flt3L would protect against cutaneous<jats:italic>Leishmania major<\/jats:italic>infection. Pretreatment of disease-susceptible BALB\/c mice with 10 \u03bcg of recombinant Flt3L (rFlt3L) for 9 to 10 days before infection increased lymph node IL-12 p40 productive capacity 20-fold compared to that of saline-injected controls. Furthermore, 9 of 22 (40.9%) rFlt3L-pretreated BALB\/c mice resolved their cutaneous infections, whereas none of the 22 control BALB\/c mice healed. Healed, rFlt3L-pretreated mice did not develop disease following reinfection. Flt3L pretreatment also reduced parasite numbers 1,000-fold in the cutaneous lesions at 2 weeks after infection relative to numbers in lesions of untreated controls. However, Flt3L pretreatment did not significantly alter<jats:italic>L. major<\/jats:italic>-induced IFN-\u03b3 and IL-4 production in lymph node culture at 1, 2, and 4 weeks after infection. Despite the lack of Th immune deviation, Flt3L ligand-pretreated lymph nodes expressed up to 10-fold higher levels of IL-12 p40 and inducible (type 2) nitric oxide synthase mRNA at 7 days after infection. In contrast, treatment with rFlt3L after infection failed to protect against disease despite comparable expansions of dendritic cells and IL-12 p40 productive capacity in both infected and uninfected BALB\/c mice treated with rFlt3L. We conclude that rFlt3L pretreatment before infection with<jats:italic>L. major<\/jats:italic>reduces parasite load and promotes healing of cutaneous lesions without stable cytokine deviation towards a dominant Th1 cytokine phenotype.<\/jats:p>","DOI":"10.1128\/iai.69.2.673-680.2001","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:03:59Z","timestamp":1027764239000},"page":"673-680","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":19,"title":["Pretreatment with Recombinant Flt3 Ligand Partially Protects against Progressive Cutaneous Leishmaniasis in Susceptible BALB\/c Mice"],"prefix":"10.1128","volume":"69","author":[{"given":"Inger B.","family":"Kremer","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Department of Dermatology, University Hospitals of Cleveland,1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meetha P.","family":"Gould","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Division of Geographic Medicine, Case Western Reserve University,2 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin D.","family":"Cooper","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Dermatology, University Hospitals of Cleveland,1"},{"name":"<!--label omitted: 3-->VA Medical Center,3 Cleveland, Ohio 44106"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick P.","family":"Heinzel","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Division of Geographic Medicine, Case Western Reserve University,2 and"},{"name":"<!--label omitted: 3-->VA Medical Center,3 Cleveland, Ohio 44106"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1636090"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.183.2.515"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.4049\/jimmunol.148.4.1182","article-title":"IL-4 induces a Th2 response in Leishmania major-infected mice","volume":"148","author":"Chatelain R.","year":"1992","unstructured":"Chatelain R. Varkila K. Coffman R. L. IL-4 induces a Th2 response in Leishmania major-infected mice.J. Immunol.148199211821187","journal-title":"J. Immunol."},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.4049\/jimmunol.153.9.4142","article-title":"Differential effects of blockade of CD28\u2013B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis","volume":"153","author":"Corry D. B.","year":"1994","unstructured":"Corry D. B. Reiner S. L. Linsley P. S. Locksley R. M. Differential effects of blockade of CD28\u2013B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis.J. Immunol.153199441424148","journal-title":"J. Immunol."},{"key":"e_1_3_2_6_2","first-page":"380","article-title":"FLT3 ligand administration inhibits tumor growth in murine melanoma and lymphoma","volume":"58","author":"Esche C.","year":"1998","unstructured":"Esche C. Subbotin V. M. Maliszewski C. Lotze M. T. Shurin M. R. FLT3 ligand administration inhibits tumor growth in murine melanoma and lymphoma.Cancer Res.581998380383","journal-title":"Cancer Res."},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199802)28:02<525::AID-IMMU525>3.0.CO;2-M"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/7403"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199811)28:11<3800::AID-IMMU3800>3.0.CO;2-0"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.4049\/jimmunol.150.5.1857","article-title":"Leishmania major interferes with antigen presentation by infected macrophages","volume":"150","author":"Fruth U.","year":"1993","unstructured":"Fruth U. Solioz N. Louis J. A. Leishmania major interferes with antigen presentation by infected macrophages.J. Immunol.150199318571864","journal-title":"J. Immunol."},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"730","DOI":"10.4049\/jimmunol.155.2.730","article-title":"Endogenous interleukin-12 (IL-12) is required for control of Th2 CD4+ T cell responses capable of exacerbating leishmaniasis in normally resistant C57BL\/6 mice","volume":"155","author":"Heinzel F. P.","year":"1995","unstructured":"Heinzel F. P. Rerko R. M. Ahmed F. Pearlman E. Endogenous interleukin-12 (IL-12) is required for control of Th2 CD4+ T cell responses capable of exacerbating leishmaniasis in normally resistant C57BL\/6 mice.J. Immunol.1551995730739","journal-title":"J. Immunol."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1006\/cimm.1998.1267"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.177.5.1505"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80435-5"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.4049\/jimmunol.156.4.1402","article-title":"IL-12 synthesis by human Langerhans cells","volume":"156","author":"Kang K.","year":"1996","unstructured":"Kang K. Kubin M. Cooper K. D. Lessin S. R. Trinchieri G. Rook A. H. IL-12 synthesis by human Langerhans cells.J. Immunol.156199614021407","journal-title":"J. Immunol."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830260216"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199906)29:06<1803::AID-IMMU1803>3.0.CO;2-F"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0697-625"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.3.587"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.184.5.1953"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.3.1458"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"5347","DOI":"10.4049\/jimmunol.160.11.5347","article-title":"Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase\/arginase balance: competitive regulation by CD4+ T cells correlates with Th1\/Th2 phenotype","volume":"160","author":"Munder M.","year":"1998","unstructured":"Munder M. Eichmann K. Modolell M. Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase\/arginase balance: competitive regulation by CD4+ T cells correlates with Th1\/Th2 phenotype.J. Immunol.160199853475354","journal-title":"J. Immunol."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.4049\/jimmunol.151.4.2050","article-title":"Antigen presentation capacity of murine macrophages infected with Leishmania amazonensis amastigotes","volume":"151","author":"Prina E.","year":"1993","unstructured":"Prina E. Jouanne C. de Souza Lao S. Szabo A. Guillet J. G. Antoine J. C. Antigen presentation capacity of murine macrophages infected with Leishmania amazonensis amastigotes.J. Immunol.151199320502061","journal-title":"J. Immunol."},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.4049\/jimmunol.156.11.4318","article-title":"Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages","volume":"156","author":"Prina E.","year":"1996","unstructured":"Prina E. Lang T. Glaichenhaus N. Antoine J. C. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages.J. Immunol.156199643184327","journal-title":"J. Immunol."},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.4049\/jimmunol.159.5.2222","article-title":"Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice","volume":"159","author":"Pulendran B.","year":"1997","unstructured":"Pulendran B. Lingappa J. Kennedy M. K. Smith J. Teepe M. Rudensky A. Maliszewski C. R. Maraskovsky E. Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice.J. Immunol.159199722222231","journal-title":"J. Immunol."},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.3.1036"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.188.11.2075"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.13.040195.001055"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.179.2.447"},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.4049\/jimmunol.139.4.1303","article-title":"Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells","volume":"139","author":"Sadick M. D.","year":"1987","unstructured":"Sadick M. D. Heinzel F. P. Shigekane V. M. Fisher W. L. Locksley R. M. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.J. Immunol.139198713031309","journal-title":"J. Immunol."},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4049\/jimmunol.136.2.655","article-title":"Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-\u03b3 in response to leishmania antigens in vitro","volume":"136","author":"Sadick M. D.","year":"1986","unstructured":"Sadick M. D. Locksley R. M. Tubbs C. Raff H. V. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-\u03b3 in response to leishmania antigens in vitro.J. Immunol.1361986655661","journal-title":"J. Immunol."},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1006\/cimm.1997.1152"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.3.783"},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.4049\/jimmunol.160.12.5815","article-title":"Expanding dendritic cells in vivo enhances the induction of oral tolerance","volume":"160","author":"Viney J. L.","year":"1998","unstructured":"Viney J. L. Mowat A. M. O'Malley J. M. Williamson E. Fanger N. A. Expanding dendritic cells in vivo enhances the induction of oral tolerance.J. Immunol.160199858155825","journal-title":"J. Immunol."},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.188.8.1547"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1999.00824.x"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830250435"}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.69.2.673-680.2001","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.69.2.673-680.2001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T15:45:46Z","timestamp":1682264746000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.69.2.673-680.2001"}},"subtitle":[],"editor":[{"suffix":"Jr.","given":"W. A.","family":"Petri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2001,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,2]]}},"alternative-id":["10.1128\/IAI.69.2.673-680.2001"],"URL":"https:\/\/doi.org\/10.1128\/iai.69.2.673-680.2001","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,2]]},"assertion":[{"value":"2000-07-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2000-11-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-02-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}